Innovations driving drug discovery breakthroughs and shaping future-ready strategies
The most transformative breakthroughs are emerging at the intersection of AI, multi-omics, biomarker development, and biospecimen strategy—each critical for capturing the biological variability that drives precision medicine.
In this on-demand webinar, leaders from Precision for Medicine, SOPHiA GENETICS, and Olink (part of Thermo Fisher Scientific) share insights from the forefront of multi-omics integration, AI-powered analytics, genomics, and high-plex proteomics. Explore cutting-edge practices and gain a forward-looking perspective on where the field is headed in 2026.
Key takeaways:
- Perspectives from Industry Leaders: Hear from the teams behind the most innovative AI, genomic and proteomic technologies used by top biopharma companies.
- Strategic Integration Discussion: Explore how aligning biospecimen planning, assay development, and data analytics, powered by multi-omics, can enable more predictive biomarkers for clinical decision-making.
- Implementation Framework: Gain a practical roadmap for connecting AI to multi-omic assay workflows, how to implement a successful biospecimen strategy, and how to build a successful multi-omic strategy
Access the on-demand webinar today!
Offered Free by: Precision for Medicine
See All Resources from: Precision for Medicine
